Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma

Title
Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 21, Issue 4, Pages 712-720
Publisher
American Association for Cancer Research (AACR)
Online
2014-12-19
DOI
10.1158/1078-0432.ccr-14-2468

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now